Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism CCR9 antagonists(C-C chemokine receptor type 9 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | CA | - | |
Neoplasms | Preclinical | CA | - |